Prevalence of Migraine Disease in Electrohypersensitive Patients

University Hospital, Montpellier1 site in 1 country317 target enrollmentApril 30, 2021

ConditionsHeadache Migraine

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Headache
Sponsor: University Hospital, Montpellier
Enrollment: 317
Locations: 1
Primary Endpoint: Possible migraine attack
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The investigators propose here by the use of the French version of the migraine disease screening questionnaire (ID Migraine ™) to study the prevalence of migraine disease in a population of electrohypersensitive patients

Registry

clinicaltrials.gov

Start Date

April 30, 2021

End Date

January 30, 2022

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University Hospital, Montpellier

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Possible migraine attack

Time Frame: 12 months

With the number of positive response to the French version of the migraine disease screening questionnaire, we are looking for the patients declaring themselves electrohypersensitive if they have had headaches in the last 12 months with characteristics that could evoke a migraine attack.